AXSM logo

Axsome Therapeutics (AXSM)

Profile

Full Name

Axsome Therapeutics, Inc.

Ticker Symbol

AXSM

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 19, 2015

Indexes

Not included

Website

http://www.axsome.com

Employees

712

Key Details

Price

$103.36(+0.77%)

Market cap

$5.09B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$385.69M(+42.53% YoY)

Annual EPS

-$5.99(-13.66% YoY)

PE ratio

-

Next earnings date

Aug 5, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $103.36
    AXSM price is $103.36

    30-Day Relative Volume

    1.42
    AXSM 30-day relative volume is 1.42

    Price Performance

    Price Today change

    +0.77%
    AXSM price is up +0.77% today

    Price YTD change

    +22.16%
    AXSM price is up +22.16% since January 1st

    Price 1-year change

    +29.05%
    AXSM price is up +29.05% year-on-year

    Price 3-year change

    +179.13%
    AXSM price is up +179.13% over the past 3 years

    Price Range

    Price All-time high

    $139.13
    AXSM price is currently -25.71% below its historical high of $139.13

    Price 3-year low

    $32.60
    AXSM price is currently +217.06% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $5.09B
    AXSM market capitalization is $5.09 billion

    Market cap 3-year change

    +253.17%
    AXSM market capitalization is up +253.17% over the past 3 years

    Market cap All-time high

    $6.76B
    AXSM market capitalization is currently -24.76% below its historical high of $6.76 billion

    Market cap sector rank

    88.95%
    AXSM market capitalization is higher than 88.95% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +3.66%
    AXSM shares outstanding is up +3.66% year-on-year

    Shares Outstanding 3-Year Change

    +26.53%
    AXSM shares outstanding is up +26.53% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.67
    AXSM beta is 0.67

    200-day SMA

    $102.74
    AXSM price is currently +0.60% above its 200-day simple moving average

    50-day SMA

    $106.68
    AXSM price is currently -3.11% below its 50-day simple moving average

    RSI

    43.11
    AXSM 14-day relative strength index is 43.11

    Volume

    1.42
    AXSM 30-day relative volume is 1.42

    ATR

    $3.38
    AXSM average true range is $3.38

    10-day Historical Volatility

    26.41%
    AXSM 10-day historical volatility is 26.41%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $385.69M
    AXSM annual revenue is $385.69 million

    Revenue Analysts estimate

    $612.32M
    AXSM annual revenue is currently -37.01% lower than the consensus analysts' forecast

    Revenue 1-year change

    +42.53%
    AXSM annual revenue is up +42.53% year-on-year

    Revenue Sector rank

    71.27%
    AXSM annual revenue is higher than 71.27% of companies in Healthcare sector

    EPS

    EPS

    -$5.99
    AXSM annual earnings per share is -$5.99

    EPS Analysts estimate

    -$3.60
    AXSM annual earnings per share is currently +66.41% higher than the consensus analysts' forecast

    EPS 1-year change

    -13.66%
    AXSM annual earnings per share is down -13.66% year-on-year

    EPS Sector rank

    17.3%
    AXSM annual earnings per share is higher than 17.3% of companies in Healthcare sector

    Profit

    Gross profit

    $352.39M
    AXSM annual gross profit is $352.39 million

    Gross margin

    91.37%
    AXSM annual gross profit margin is 91.37%

    Operating profit

    -$252.44M
    AXSM annual operating income is -$252.44 million

    Operating margin

    -65.45%
    AXSM annual operating profit margin is -65.45%

    Net income

    -$287.22M
    AXSM annual net profit is -$287.22 million

    Net margin

    -74.47%
    AXSM annual net profit margin is -74.47%

    Expenses

    Total expenses

    $638.13M
    AXSM annual total expenses is $638.13 million

    Operating expenses

    $604.83M
    AXSM annual total operating expenses is $604.83 million

    Cost of goods sold

    $33.30M
    AXSM annual cost of goods sold is $33.30 million

    Selling, general & administrative expenses

    $411.36M
    AXSM annual SGA is $411.36 million

    Depreciation and amortization

    $7.96M
    AXSM annual depreciation & amortization is $7.96 million

    Interest expense

    $6.57M
    AXSM annual interest expense is $6.57 million

    Income tax

    $85.00K
    AXSM annual income tax is $85.00 thousand

    EBIT & EBITDA

    EBIT

    -$280.56M
    AXSM annual earnings before interest & taxes is -$280.56 million

    EBITDA

    -$272.60M
    AXSM annual EBITDA is -$272.60 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $568.50M
    AXSM annual total assets is $568.50 million

    Non current assets

    $83.43M
    AXSM annual long term assets is $83.43 million

    Current assets

    $485.06M
    AXSM annual total current assets is $485.06 million

    Cash and cash equivalents

    $315.35M
    AXSM annual cash & cash equivalents is $315.35 million

    Accounts receivable

    $142.00M
    AXSM annual accounts receivable is $142.00 million

    Inventory

    $15.73M
    AXSM annual inventory is $15.73 million

    Liabilities

    Total liabilities

    $511.48M
    AXSM annual total liabilities is $511.48 million

    Long term liabilities

    $281.38M
    AXSM annual total long term liabilities is $281.38 million

    Current liabilities

    $230.10M
    AXSM annual total current liabilities is $230.10 million

    Accounts payable

    $72.00M
    AXSM annual accounts payable is $72.00 million

    Debt

    Total debt

    $192.96M
    AXSM annual total debt is $192.96 million

    Total debt 1-year change

    +3.53%
    AXSM annual total debt is up +3.53% year-on-year

    Long term debt

    $189.70M
    AXSM annual long term debt is $189.70 million

    Short term debt

    $3.26M
    AXSM annual short term debt is $3.26 million

    Equity & Capital

    Shareholders equity

    $57.02M
    AXSM annual stockholders equity is $57.02 million

    Book value

    $57.02M
    AXSM annual book value is $57.02 million

    Retained earnings

    -$1.12B
    AXSM annual retained earnings is -$1.12 billion

    Working capital

    $254.96M
    AXSM annual working capital is $254.96 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$128.41M
    AXSM annual cash flow from operations is -$128.41 million

    Cash from operations 1-year change

    +11.49%
    AXSM annual cash flow from operations is up +11.49% year-on-year

    Cash from investing

    -$270.00K
    AXSM annual cash flow from investing activities is -$270.00 thousand

    Cash from investing 1-year change

    +53.61%
    AXSM annual cash flow from investing activities is up +53.61% year-on-year

    Cash from financing

    $57.84M
    AXSM annual cash flow from financing activities is $57.84 million

    Cash from financing 1-year change

    -82.53%
    AXSM annual cash flow from financing activities is down -82.53% year-on-year

    CAPEX

    CAPEX

    $270.00K
    AXSM annual capital expenditures is $270.00 thousand

    CAPEX 1-year change

    -53.61%
    AXSM annual capital expenditures is down -53.61% year-on-year

    Free Cash Flow

    Free cash flow

    -$128.68M
    AXSM annual free cash flow is -$128.68 million

    Free cash flow 1-year change

    +11.66%
    AXSM annual free cash flow is up +11.66% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    91.37%
    AXSM annual gross profit margin is 91.37%

    Operating margin

    -65.45%
    AXSM annual operating profit margin is -65.45%

    Net margin

    -74.47%
    AXSM annual net profit margin is -74.47%

    ROA & ROE

    ROA

    -49.66%
    AXSM annual return on assets is -49.66%

    ROE

    -231.63%
    AXSM annual return on equity is -231.63%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    AXSM price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    AXSM price to earnings ratio is unknown

    PB Ratio

    PB ratio

    95.65
    AXSM price to book ratio is 95.65

    PB ratio Sector rank

    99.26%
    AXSM price to book ratio is higher than 99.26% of companies in Healthcare sector

    PS Ratio

    PS ratio

    11.78
    AXSM price to sales ratio is 11.78

    PS ratio Sector rank

    80%
    AXSM price to sales ratio is higher than 80% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $5.00B
    AXSM enterprise value is $5.00 billion

    Enterprise value Sector rank

    87.8%
    AXSM enterprise value is higher than 87.8% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -19.08
    AXSM EV/EBITDA is -19.08

    EV/EBITDA Sector rank

    7.48%
    AXSM EV/EBITDA is higher than 7.48% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.11
    AXSM annual current ratio is 2.11

    Quick ratio

    2.04
    AXSM annual quick ratio is 2.04

    Leverage

    Debt to equity

    3.17
    AXSM annual debt to equity ratio is 3.17

    Interest coverage ratio

    -42.71
    AXSM annual interest coverage ratio is -42.71

    Risk & Stability

    Piotroski F-Score

    3
    AXSM piotroski f-score is 3

    Altman Z-Score

    2.79
    AXSM altman z-score is 2.79

    Analyst ratings

    Recent major analysts updates

    Jun 12, 25 RBC Capital
    Outperform
    Jun 10, 25 HC Wainwright & Co.
    Buy
    Jun 9, 25 Needham
    Buy
    Jun 3, 25 Oppenheimer
    Outperform
    May 22, 25 HC Wainwright & Co.
    Buy
    May 7, 25 HC Wainwright & Co.
    Buy
    May 6, 25 Wells Fargo
    Overweight
    May 6, 25 Baird
    Outperform
    Apr 29, 25 RBC Capital
    Outperform
    Apr 7, 25 Jefferies
    Buy

    Institutional Ownership

    Screeners with AXSM included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Axsome Therapeutics?
    • Does Axsome Therapeutics pay dividends?
    • What sector is Axsome Therapeutics in?
    • What industry is Axsome Therapeutics in?
    • What country is Axsome Therapeutics based in?
    • When did Axsome Therapeutics go public?
    • Is Axsome Therapeutics in the S&P 500?
    • Is Axsome Therapeutics in the NASDAQ 100?
    • Is Axsome Therapeutics in the Dow Jones?
    • When was Axsome Therapeutics's last earnings report?
    • When does Axsome Therapeutics report earnings?
    • Should I buy Axsome Therapeutics stock now?

    What is the ticker symbol for Axsome Therapeutics?

    The ticker symbol for Axsome Therapeutics is NASDAQ:AXSM

    Does Axsome Therapeutics pay dividends?

    No, Axsome Therapeutics does not pay dividends

    What sector is Axsome Therapeutics in?

    Axsome Therapeutics is in the Healthcare sector

    What industry is Axsome Therapeutics in?

    Axsome Therapeutics is in the Biotechnology industry

    What country is Axsome Therapeutics based in?

    Axsome Therapeutics is headquartered in United States

    When did Axsome Therapeutics go public?

    Axsome Therapeutics's initial public offering (IPO) was on November 19, 2015

    Is Axsome Therapeutics in the S&P 500?

    No, Axsome Therapeutics is not included in the S&P 500 index

    Is Axsome Therapeutics in the NASDAQ 100?

    No, Axsome Therapeutics is not included in the NASDAQ 100 index

    Is Axsome Therapeutics in the Dow Jones?

    No, Axsome Therapeutics is not included in the Dow Jones index

    When was Axsome Therapeutics's last earnings report?

    Axsome Therapeutics's most recent earnings report was on May 5, 2025

    When does Axsome Therapeutics report earnings?

    The next expected earnings date for Axsome Therapeutics is Aug 5, 2025

    Should I buy Axsome Therapeutics stock now?

    As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page